A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response

Nature

Volumn 431, Issue 7004, 2004, Pages 84-87

  Reed, Michael B ^a   Domenech, Pilar ^a   Manca, Claudia ^b   Su, Hua ^a,d   Barczak, Amy K ^a   Kreiswirth, Barry N ^c   Kaplan, Gilla ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b Lab of Mycobac Immun/Pathogenesis   (United States)

^c PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; GLYCOLIPID; MULTIENZYME COMPLEX; INTERLEUKIN 12; INTERLEUKIN 6; PHENOLIC GLYCOLIPID; POLYKETIDE SYNTHASE; SYNTHETASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BONE MARROW CELL; CHEMISTRY; CLASSIFICATION; CYTOLOGY; DISEASE MODEL; IMMUNOLOGY; INNATE IMMUNITY; MACROPHAGE; METABOLISM; MICROBIOLOGY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; PATHOGENICITY; PHENOTYPE; SECRETION; TUBERCULOSIS; VIRULENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DISEASE COURSE; DOSE RESPONSE; GENETIC HETEROGENEITY; HOST RESISTANCE; IMMUNE RESPONSE; IN VITRO STUDY; LIPOGENESIS; MONOCYTE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; BONE MARROW CELLS; DISEASE MODELS, ANIMAL; GLYCOLIPIDS; IMMUNITY, NATURAL; INFLAMMATION MEDIATORS; MACROPHAGES; MICE; MULTIENZYME COMPLEXES; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; TUBERCULOSIS; VIRULENCE;

BIODIVERSITY; LIPIDS; PATHOLOGY; TUMORS;

GENETIC HETEROGENEITY; TUBERCULOSIS;

IMMUNOLOGY;

MEDICINE; TUBERCULOSIS;

ACTINOBACTERIA (CLASS); ANIMALIA; BACTERIA (MICROORGANISMS); MURINAE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 4544298326     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature02837     Document Type: Letter

References (30)

1. Tiruviluamala, P. & Reichman, L. B. Tuberculosis. Annu. Rev. Publ Health 23, 403-426 (2002).
2. Sreevatsan, S. et al. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complexindicates evolutionarily recent global dissemination. Proc. NatlAcad. Sci. USA 94, 9869-9874 (1997).
3. Fleischmann, R. D. et al. Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J. Bacteriol. 184, 5479-5490 (2002).
4. North, R. J., Ryan, L., LaCource, R., Mogues, T. & Goodrich, M. E. Growth rate of mycobacteria in mice as an unreliable indicator of mycobacterial virulence. Infect. Immun. 67, 5483-5485 (1999).
5. Manca, C. et al. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J. Immunol. 162, 6740-6746 (1999).
6. Manca, C. et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failureto induce Th1 type immunity and is associated with induction ofIFN-a/3. Proc. NatlAcad. Sci. USA 98, 5752-5757 (2001).
7. Valway, S.E. et al. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N. Engl. J. Med. 338, 633-639 (1998).
8. Bifani, P. J., Mathema, B., Kurepina, N. E. & Kreiswirth, B. N. Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends Microbiol. 10, 45-52 (2002).
9. Glynn, J. R., Whiteley, J., Bifani, P. J., Kremer, K. & van Soolingen, D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg. Infect. Dis. 8, 843-849 (2002).
10. Cole, S. T. et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537-544 (1998).
11. Manca, C. et al. Differential monocyte activation underlies strain specific M. tuberculosis pathogenesis. Infect. Immun. (in the press).
12. Cox, J. S., Chen, B., McNeil, M. & Jacobs, W. R. Jr Complexlipiddeterminestissue-specific replication ofMycobacterium tuberculosis in mice. Nature 402, 79-83 (1999).
13. Sirakova, T. D., Thirumala, A. K., Dubey, V.S., Sprecher, H. & Kolattukudy, P. E. The Mycobacterium tuberculosis pks2 gene encodes the synthase for the hepta- and octamethyl-branched fatty acids required for sulfolipid synthesis. J. Biol. Chem. 276, 16833-16839 (2001).
14. Constant, P. et al. Role of the pks15/1 gene in the biosynthesis of phenolglycolipids in the Mycobacterium tuberculosis complex. Evidence that all strains synthesize glycosylated p-hydroxybenzoic methly esters and that strains devoid of phenolglycolipids harbor a frameshift mutation in the pks15/1 gene. J. Biol. Chem. 277, 38148-38158 (2002).
15. Marmiesse, M. et al. Macro-array and bioinformatic analyses reveal mycobacterial ‘core’ genes, variation in the ESAT-6 gene family and new phylogenetic markers for the Mycobacterium tuberculosis complex. Microbiol. 150, 483-496 (2004).
16. Kolattukudy, P. E., Fernandes, N. D., Azad, A. K., Fitzmaurice, A. M. & Sirakova, T. D. Biochemistry and molecular genetics of cell-wall lipid biosynthesis in mycobacteria. Mol. Microbiol. 24, 263-270 (1997).
17. Vergne, I. I. & Daffe, M. Interaction of mycobacterial glycolipids with host cells. Front. Biosci. 3, 865-876 (1998).
18. Hunter, S. W. & Brennan, P. J. A novel phenolic glycolipid from Mycobacterium leprae possibly involved in immunogenicity and pathogenicity. J. Bacteriol. 147, 728-735 (1981).
19. Mehra, V., Brennan, P. J., Rada, E., Convit, J. & Bloom, B. R. Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Nature 308, 194-196 (1984).
20. Fournie, J.-J., Adams, E., Mullins, R. J. & Basten, A. Inhibition of human lymphoproliferative responses by mycobacterial phenolic glycolipids. Infect. Immun. 57, 3653-3659 (1989).
21. Vachula, K., Holzer, T. J. & Andersen, B. R. suppression ofmonocyte oxidative responses by phenolic glycolipid 1 ofMycobacterium leprae. J. Immunol. 142, 1696-1701 (1989).
22. Silva, C. L., Faccioli, L. H. & Foss, N. T. Suppression ofhuman monocyte cytokine release byphenolic glycolipid-1 ofMycobacterium leprae. Int. J. Lepr. 61, 107-108 (1993).
23. Hashimoto, K. et al. Mycobacterium leprae infection in monocyte-derived dendritic cells and its influence on antigen-presenting function. Infect. Immun. 70, 5167-5176 (2002).
24. Ng, V. et al. Role of the cell wall phenolic glycolipid-1 in the peripheral nerve predilection of Mycobacterium leprae. Cell 103, 511-524 (2000).
25. Stover, C. K. et al. New use of BCG for recombinant vaccines. Nature 351, 456-460 (1991).
26. Gordon, S. Alternative activation ofmacrophages. Nature Rev. Immunol. 3, 23-35 (2003).
27. Garbe, T. R. et al. Transformation of mycobacterial species using hygromycin resistance as selectable marker. Microbiol. 140, 133-138 (1994).
28. Pelicic, V. et al. Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis. Proc. NatlAcad. Sci. USA 94, 10955-10960 (1997).
29. O’Gaora, P. et al. Mycobacteriaas immunogens: developmentofexpressionvectors for use in multiple mycobacterial species. Med. Princ. Prac. 6, 91-96 (1997).
30. Slayden, R. A. & Barry, C.E. III in Mycobacterium tuberculosisprotocols (eds Parish, T. & Stoker, N.G.) 229-245 (Humana, New Jersey, 2001).